← Back

Wire · opportunities

FDA clears next-gen peripheral thrombectomy device

Published

13 August 2026

Topic

opportunities

◆ Sectors

Medtech

◆ Geography

United States

◆ Source

Read at cardiovascularbusiness.com →

◆ Verified

Fusion42 · 13 August 2026 · Fusion42 review

Vesalio has received FDA clearance for its next-generation peripheral mechanical thrombectomy device, the pVasc NET, featuring a dual-layer distal filter for improved emboli capture during minimally invasive procedures in peripheral blood vessels.

This Wire brief sits within Fusion42's coverage of Medtech, and 3 sources have reported it.

◆ ◆ The Wire takeaway

You can now position your medtech startup to incorporate or compete with more sophisticated thrombectomy tech in peripheral vascular care as FDA clearance lowers barriers for innovative devices like Vesalio’s pVasc NET.

◆ Coverage

3 sources · 13 Aug 2026

◆ Related on Wire

◆ Topics

Medtechfda-clearancemedical-devicethrombectomyperipheral-vascularmedtech